Triazine 11-beta hydroxysteroid dehydrogenase type 1 inhibitors
Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds have the structure:or stereoisomers or prodrugs or pharmaceutically acceptable salts thereof, wherein R1, R2 and R3 are defined herein.
Bristol-Myers Squibb Company
A C A A A C
A61P C07D A61P A61P A61P C07D
inventional inventional inventional inventional inventional inventional
Jun Jeffrey A. Lawrence J.
Li Robl Kennedy